Comorbidity-Adjusted Life Expectancy: A New Tool to Inform Recommendations for Optimal Screening Strategies

BACKGROUND Many guidelines recommend considering health status and life expectancy when making cancer screening decisions for elderly persons. OBJECTIVE To estimate life expectancy for elderly persons without a history of cancer, taking into account comorbid conditions. DESIGN Population-based cohort study. SETTING A 5% sample of Medicare beneficiaries in selected geographic areas, including their claims and vital status information. PARTICIPANTS Medicare beneficiaries aged 66 years or older between 1992 and 2005 without a history of cancer (n = 407 749). MEASUREMENTS Medicare claims were used to identify comorbid conditions included in the Charlson index. Survival probabilities were estimated by comorbidity group (no, low/medium, and high) and for the 3 most prevalent conditions (diabetes, chronic obstructive pulmonary disease, and congestive heart failure) by using the Cox proportional hazards model. Comorbidity-adjusted life expectancy was calculated based on comparisons of survival models with U.S. life tables. Survival probabilities from the U.S. life tables providing the most similar survival experience to the cohort of interest were used. RESULTS Persons with higher levels of comorbidity had shorter life expectancies, whereas those with no comorbid conditions, including very elderly persons, had favorable life expectancies relative to an average person of the same chronological age. The estimated life expectancy at age 75 years was approximately 3 years longer for persons with no comorbid conditions and approximately 3 years shorter for those with high comorbidity relative to the average U.S. population. LIMITATIONS The cohort was limited to Medicare fee-for-service beneficiaries aged 66 years or older living in selected geographic areas. Data from the Surveillance, Epidemiology, and End Results cancer registry and Medicare claims lack information on functional status and severity of comorbidity, which might influence life expectancy in elderly persons. CONCLUSION Life expectancy varies considerably by comorbidity status in elderly persons. Comorbidity-adjusted life expectancy may help physicians tailor recommendations for stopping or continuing cancer screening for individual patients.

[1]  Eric J Feuer,et al.  Life tables adjusted for comorbidity more accurately estimate noncancer survival for recently diagnosed cancer patients. , 2013, Journal of clinical epidemiology.

[2]  Thomas M. Gill,et al.  The central role of prognosis in clinical decision making. , 2012, JAMA.

[3]  S Kamen,et al.  The task force. , 1976, Journal of hospital dental practice.

[4]  E. Feuer,et al.  The Cancer Survival Query System: Making survival estimates from the Surveillance, Epidemiology, and End Results program more timely and relevant for recently diagnosed patients , 2012, Cancer.

[5]  P. Shekelle,et al.  Screening for Colorectal Cancer: A Guidance Statement From the American College of Physicians , 2012, Annals of Internal Medicine.

[6]  T. Panzarella,et al.  Accuracy of survival prediction by palliative radiation oncologists. , 2005, International journal of radiation oncology, biology, physics.

[7]  American Geriatrics Society Ethics Committee.  Health Screening Decisions for Older Adults: AGS Position Paper , 2003, Journal of the American Geriatrics Society.

[8]  L. Walter,et al.  Cancer screening in elderly patients: a framework for individualized decision making. , 2001, JAMA.

[9]  W. Lawrence,et al.  Toward optimal screening strategies for older women , 2005, Journal of General Internal Medicine.

[10]  J. Lynn,et al.  Predicting life span for applicants to inpatient hospice. , 1988, Archives of internal medicine.

[11]  Timothy J Wilt,et al.  Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.

[12]  R. Prentice,et al.  Commentary on Andersen and Gill's "Cox's Regression Model for Counting Processes: A Large Sample Study" , 1982 .

[13]  J L Warren,et al.  Development of a comorbidity index using physician claims data. , 2000, Journal of clinical epidemiology.

[14]  Carmen L. Lewis,et al.  Screening for colorectal, breast, and cervical cancer in the elderly: a review of the evidence. , 2005, The American journal of medicine.

[15]  J L Warren,et al.  Measuring the incidence of cancer in elderly americans using medicare claims data , 1994, Cancer.

[16]  C. Klabunde,et al.  Assessing Comorbidity Using Claims Data: An Overview , 2002, Medical care.

[17]  Lester R Curtin,et al.  U.S. decennial life tables for 1999-2001, United States life tables. , 2008, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[18]  W. P. Evans,et al.  American Cancer Society Guidelines for Breast Cancer Screening: Update 2003 , 2003, CA: a cancer journal for clinicians.

[19]  N. Christakis,et al.  Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study , 2000, BMJ : British Medical Journal.

[20]  J. Wardle,et al.  The psychological costs of screening for cancer. , 1992, Journal of psychosomatic research.

[21]  F. Saad,et al.  Predicting life expectancy in prostate cancer patients , 2009, Current opinion in supportive and palliative care.

[22]  E. Keeler,et al.  The impact of functional status on life expectancy in older persons. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[23]  E L Korn,et al.  Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. , 1997, American journal of epidemiology.

[24]  E. Feuer,et al.  Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence. , 2013, American journal of epidemiology.

[25]  P. Ubel,et al.  The use of life expectancy in cancer screening guidelines , 2005, Journal of General Internal Medicine.

[26]  C. Klabunde,et al.  Data Sources for Measuring Comorbidity: A Comparison of Hospital Records and Medicare Claims for Cancer Patients , 2006, Medical care.

[27]  A. Muñoz,et al.  Left-truncated data with age as time scale: an alternative for survival analysis in the elderly population. , 1998, The journals of gerontology. Series A, Biological sciences and medical sciences.

[28]  Practice bulletin no. 122: Breast cancer screening. , 2011, Obstetrics and gynecology.

[29]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[30]  Bernadette Mazurek Melnyk,et al.  Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.

[31]  V. Moyer,et al.  Screening for Cervical Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.

[32]  C. Klabunde,et al.  A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. , 2007, Annals of epidemiology.

[33]  D. Reuben.  Medical care for the final years of life: "When you're 83, it's not going to be 20 years". , 2009, JAMA.

[34]  K. Kupka,et al.  International classification of diseases: ninth revision. , 1978, WHO chronicle.

[35]  D. Howard.  Life expectancy and the value of early detection. , 2005, Journal of health economics.

[36]  Deborah Schrag,et al.  Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population , 2002, Medical care.

[37]  U. P. S. T. Force,et al.  Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement , 2011, Annals of Internal Medicine.